Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2026-01-03 @ 8:35 PM
Study NCT ID:
NCT02781727
Status:
COMPLETED
Last Update Posted:
2022-01-04
First Post:
2016-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Sponsor:
Ascendis Pharma Endocrinology Division A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-19
First Submit QC Date:
None
Study First Post Date:
2016-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-24
Results First Submit QC Date:
None
Results First Post Date:
2022-01-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-12-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-12-06
Last Update Post Date:
2022-01-04
Last Update Post Date Type:
ACTUAL